CPHI Earnings

Quarterly EPS
$-0.65
Q3 2024
$-0.53
Q4 2024
$-0.24
Q1 2025
$-0.16
Q2 2025
$-0.17
Q3 2025
$-0.18
Q4 2025
$-0.04
Q1 2026
$-0.04
Q2 2026
Latest Revenue948.3K
Latest Net Income-1458123
EPS & Revenue Trend
PeriodEPSRevenueNet IncomeRev YoYEPS YoY
Q2 2026-$0.04948.3K-1458123-7.5%+75.0%
Q1 2026-$0.04983.5K-1143148-13.4%+83.3%
Q4 2025-$0.181.2M-1222135+8.1%+66.0%
Q3 2025-$0.17756.2K-651482-31.3%+73.8%
Q2 2025-$0.161.0M-528367+10.9%+82.0%
Q1 2025-$0.241.1M-785572-17.0%+66.7%
Q4 2024-$0.531.1M-1224432-47.2%+67.3%
Q3 2024-$0.651.1M-1117911-39.0%+77.6%
Q2 2024-$0.89924.9K-1438130
Q1 2024-$0.721.4M-955892
Q4 2023-$1.622.1M-1232213
Q3 2023-$2.901.8M-777600
China Pharma (CPHI) — Earnings